Trimethoprim resistance in Finland after five years' use of plain trimethoprim
- PMID: 7353129
- PMCID: PMC1600228
- DOI: 10.1136/bmj.280.6207.72
Trimethoprim resistance in Finland after five years' use of plain trimethoprim
Abstract
A total of 1388 urinary bacterial pathogens were tested for resistance to plain trimethoprim after five years' use of this drug for prophylaxis against urinary tract infections. Samples were obtained in Turku, Finland, where use of the drug is much greater than in other parts of Finland. Resistance to trimethoprim (greater than 8 mg/l; agar-dilution method) occurred in 20.3% of strains isolated from outpatients and 39.8% of strains isolated from inpatients. Escherichia coli and Micrococcus showed low incidences of resistance (11% and 13% respectively in ouptatients and 23% and 19% respectively in inpatients); Enterobacter, Streptococcus faecalis, and Staphylococcus epidermidis occupied an intermediate position; and Proteus mirabilis and Klebsiella were resistant in 41-76% of cases. Similar incidences of resistance were observed to sulphamethoxazole-trimethoprim, sulphamethoxazole, ampicillin, and nitrofurantoin. These findings together with the rare occurrence of side effects and convenient dosage confirm the usefulness of plain trimethoprim for urinary tract infection.
Similar articles
-
Trimethoprim resistance in hospitals.Br Med J (Clin Res Ed). 1982 Mar 13;284(6318):782-4. doi: 10.1136/bmj.284.6318.782. Br Med J (Clin Res Ed). 1982. PMID: 6802226 Free PMC article.
-
Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim.J Antimicrob Chemother. 1985 Oct;16(4):435-41. doi: 10.1093/jac/16.4.435. J Antimicrob Chemother. 1985. PMID: 2999058
-
Effect of trimethoprim or trimethoprim/sulphamethoxazole usage on the emergence of trimethoprim resistance in urinary tract pathogens.Scand J Infect Dis. 1981;13(3):203-10. doi: 10.3109/inf.1981.13.issue-3.08. Scand J Infect Dis. 1981. PMID: 6914810
-
Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland.Rev Infect Dis. 1982 Mar-Apr;4(2):358-65. doi: 10.1093/clinids/4.2.358. Rev Infect Dis. 1982. PMID: 7051235 Review.
-
Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.Drugs. 1982 Jun;23(6):405-30. doi: 10.2165/00003495-198223060-00001. Drugs. 1982. PMID: 7049657 Review.
Cited by
-
Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).Clin Pharmacokinet. 1980 Sep-Oct;5(5):405-23. doi: 10.2165/00003088-198005050-00001. Clin Pharmacokinet. 1980. PMID: 7408366 No abstract available.
-
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002. Drugs. 1982. PMID: 6759092 Review. No abstract available.
-
Resistance to trimethoprim in 1978-79 compared with 1973-75.J Clin Pathol. 1981 Apr;34(4):439-42. doi: 10.1136/jcp.34.4.439. J Clin Pathol. 1981. PMID: 7016927 Free PMC article.
-
Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.Eur J Clin Pharmacol. 1983;24(2):267-71. doi: 10.1007/BF00613830. Eur J Clin Pharmacol. 1983. PMID: 6840178
-
Cotrimoxazole. Rationale for re-examining its indications for use.Drug Saf. 1996 Apr;14(4):213-8. doi: 10.2165/00002018-199614040-00001. Drug Saf. 1996. PMID: 8713689 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources